Abstract:The integration of biomaterials in medical applications triggers the foreign body response (FBR), a multi-stage immune reaction characterized by the formation of foreign body giant cells (FBGCs). Originating from the fusion of monocyte/macrophage lineage cells, FBGCs are pivotal participants during tissue-material interactions. This review provides an in-depth examination of the molecular processes during FBGC formation, highlighting signaling pathways and fusion mediators in response to both exogenous and endogenous stimuli. Moreover, a wide range of material-specific characteristics, such as surface chemical and physical properties, has been proven to influence the fusion of macrophages into FBGCs. Multifaceted biological activities of FBGCs are also explored, with emphasis on their phagocytic capabilities and extracellular secretory functions, which profoundly affect the vascularization, degradation, and encapsulation of the biomaterials. This review further elucidates the heterogeneity of FBGCs and their diverse roles during FBR, as demonstrated by their distinct behaviors in response to different materials. By presenting a comprehensive understanding of FBGCs, this review intends to provide strategies and insights into optimizing biocompatibility and the therapeutic potential of biomaterials for enhanced stability and efficacy in clinical applications. STATEMENT OF SIGNIFICANCE: As a hallmark of the foreign body response (FBR), foreign body giant cells (FBGCs) significantly impact the success of implantable biomaterials, potentially leading to complications such as chronic inflammation, fibrosis, and device failure. Understanding the role of FBGCs and modulating their responses are vital for successful material applications. This review provides a comprehensive overview of the molecules and signaling pathways guiding macrophage fusion into FBGCs. By elucidating the physical and chemical properties of materials inducing distinct levels of FBGCs, potential strategies of materials in modulating FBGC formation are investigated. Additionally, the biological activities of FBGCs and their heterogeneity in responses to different material categories in vivo are highlighted in this review, offering crucial insights for improving the biocompatibility and efficacy of biomaterials.

Foreign‐Body Responses: Dealing with the Foreign‐Body Response to Implanted Biomaterials: Strategies and Applications of New Materials (Adv. Funct. Mater. 6/2021)

Dealing with the Foreign‐Body Response to Implanted Biomaterials: Strategies and Applications of New Materials

Materials Strategies to Overcome the Foreign Body Response.

Decoding the “fingerprint” of Implant Materials: Insights into the Foreign Body Reaction

Modulating, Instead of Suppressing, Foreign Body Responses for Biomaterials Design

A Foreign Body Response‐on‐a‐Chip Platform

Recent Advances in Anti-inflammatory Strategies for Implantable Biosensors and Medical Implants

Novel Balanced Charged Alginate/PEI Polyelectrolyte Hydrogel That Resists Foreign-Body Reaction

Spermidine-functionalized biomaterials to modulate implant-induced immune response and enhance wound healing

Drug-free Antibacterial Polymers for Biomedical Applications

Unravelling & Harnessing The Immune Response at The Cell‐Biomaterial Interface for Tissue Engineering Purposes.

Fibrous Capsule-Resistant, Controllably Degradable and Functionalizable Zwitterion-Albumin Hybrid Hydrogels.

Formation and biological activities of foreign body giant cells in response to biomaterials

Covalently Grafted Human Serum Albumin Coating Mitigates the Foreign Body Response Against Silicone Implants in Mice

Elucidating osseointegration in vivo in 3D printed scaffolds eliciting different foreign body responses

Cell Membrane-Biomimetic Coating Via Click-Mediated Liposome Fusion for Mitigating the Foreign-Body Reaction.

Silk‐Inspired Β‐peptide Materials Resist Fouling and the Foreign‐Body Response

Friend or foe? Inflammation and the foreign body response to orthopedic biomaterials

Poly(Glutamic Acid‐Lysine) Hydrogels with Alternating Sequence Resist the Foreign Body Response in Rodents and Non‐Human Primates

Attenuating Chronic Fibrosis: Decreasing Foreign Body Response with Acellular Dermal Matrix

An elastomer with in situ generated pure zwitterionic surfaces for fibrosis-resistant implants